IPOs Are a Gateway to More Diverse Biotech Boards

As more biotechnology executives begin to focus on strategies to diversify their boards to avoid groupthink and strengthen corporate governance, an emerging consensus is forming that initial public offerings are a key gateway to assembling higher-performing leadership teams.
That was the unanimous consensus of a panel of experts who explored the topic at the BIO Investor Forum on Tuesday in San Francisco. The topic is especially timely for biotech companies headquartered in California, which las